Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19570619 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: < 15% risk of + LN;   Radiation: > 15% risk of + LN

Study has passed its completion date and status has not been verified in more than two years.